Director, FP&A

About Loyal Loyal is a clinical-stage veterinary medicine company developing longevity drugs for dogs. Our mission is to help dogs live longer, healthier lives. We're pioneering a new category of veterinary prescription drugs that proactively and preventatively target the underlying drivers of aging, delaying the onset of disease and preserving quality of life as dogs age. We've already made significant progress in our mission to develop the first FDA-approved drugs to extend canine lifespan: as of early 2026 we've completed two of three major FDA review sections for our lead program, LOY-002, and are targeting submission of the third and final section later this year. Loyal is a well-funded startup with teams of scientists, veterinarians, engineers, operators, and creatives. You'll help us continue on our path of earning FDA approval for the first lifespan extension medicine for any species, and change what's possible for the dogs we love. About the role Loyal is hiring a Director, FP&A to enhance and run the company's financial planning and analysis function. You will be the first hire to a building finance team, reporting directly to our VP, Finance, as the company prepares to move from a clinical-stage organization to a commercial one. This role owns the company model. You will be the analytical spine of a company doing two things at once, deploying capital across a portfolio of multi-year R&D programs and constructing the infrastructure required for future commercial operations. Your primary business partnership is with R&D, clinical operations, CMC, and program leadership,  where the majority of our spend lives and where forecast accuracy is paramount. You will start as a team of one and are expected to build the function: evaluate and select our FP&A platform, implement it, define a revised planning calendar and forecast cadence, and establish the reporting standards. This is an opportunity to shape the FP&A function rather than inheriting a set structure. We expect to expand the finance team as we approach commercial launch, with the timing and shape of that expansion tied to program milestones. This is not a role for someone who wants to inherit a working system and maintain it. The right person has helped build FP&A infrastructure before at a biotech or another R&D-heavy, milestone-based organization, knows what good looks like pre- and post-revenue, and is ready to do the work to get there. Your daily work will include - Own the company-wide financial model end to end: integrated P&L, balance sheet, and cash flow across pipeline programs, milestone timelines, and capital deployment scenarios. - Serve as the embedded finance partner to R&D leadership. Build and maintain clinical study budgets and forecasts driven by enrollment curves, site activation, per-patient costs, and CRO contract structures. Reconcile accruals against contracted work and actual study progress, and own the variance narrative when they diverge. - Partner with CMC and manufacturing leadership. Build and maintain forecasts driven by campaign timing, registration and validation batches, tech transfer, analytical and stability programs, and CMO contract structures. Implement enhanced inventory and cost-of-goods tracking ahead of commercial launch. - Help design and run the annual budget and long-range plan, including the department-level target-setting process and the headcount plan that underpins it. - Develop and deliver monthly forecast vs. actuals reporting at the department level, with variance analysis and a narrative crisp enough to go to the VP, Finance and Executive team without rework. - Lead the selection and implementation of Loyal's FP&A platform. No tool has been purchased yet, deliberately — we want the person who will implement and deploy it to have a real say in choosing it. - Partner to build the quarterly board financial package — standardized KPIs, variance analysis, and cash runway narrative — along wit